DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

48.74 -2.05 (-4.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LGND $48.74 -4.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.93
Previous Close $50.79
Daily Range $48.33 - $51.43
52-Week Range $39.75 - $80.42
Market Cap $1.0B
P/E Ratio 141.08
Dividend (Yield) $0.00 (0.0%)
Volume 1,048,761
Average Daily Volume 418,704
Current FY EPS $1.06

Sector

Healthcare

Industry

Drugs

Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website: http://www.ligand.com/

News & Commentary

3 Stocks That Soared Stupendously This Week

Double-digit gains in a shortened trading week? Here's how these 3 stocks did it.

Fr. Emmanuel Lemelson On Apple And The Positive And Negative Aspects Of Capital Formation In Public

Fr. Emmanuel Lemelson On Apple And The Positive And Negative Aspects Of Capital Formation In Public Market

IPO Preview: Viking Therapeutics

NASDAQ Biotechnology Top Performers (As Of Market Open September 11)

Ligand Inks 2nd Captisol Deal with CURx Pharmaceuticals - Analyst Blog

Update: Ligand Establishes License Agreement With CURx Pharmaceuticals

Diabetes biotech Viking Therapeutics sets terms for $55 million IPO

Ligand Pharmaceuticals Inc Stock Downgraded (LGND)

Ligand Pharmaceuticals: Institutional Holders Wasting No Time Dumping Stock In Response To Mounting

Ligand Pharmaceuticals: Institutional Holders Wasting No Time Dumping Stock In Response To Mounting Insolvency And Bankruptcy Risks

Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog

Insider Trading Alert - LGND, BRCM And TER Traded By Insiders

See More LGND News...

LGND's Top Competitors

LGND $48.74 (-4.04%)
Current stock: LGND
AMGN $144.01 (1.40%)
Current stock: AMGN
BIIB $329.24 (-0.23%)
Current stock: BIIB
CELG $93.85 (0.62%)
Current stock: CELG